【港股异动丨兆科眼科大涨近12%,股价创去年10月以来新高】近期走势明显拉升的兆科眼科-B(6622.HK)今日再度大涨,盘初一度涨近12%,报1.79港元,股价创2024年10月8日以来新高。 公开资料显示,兆科眼科专注于眼科用药的研发、生产及销售。公司已建立起由创新药及仿制药组成的产品研发组合,涵盖影响眼前节及眼后节的6种主要眼科适应症,包括干眼症、近视、老花眼、湿性老年黄斑部病变、糖尿病黄斑水肿及青光眼。此前,兆科眼科宣布用于控制儿童近视加深的药物NVK002(0.01%低剂量阿托品)的简易新药申请,获国家药监局正式受理。

金融界
14 Feb
近期走势明显拉升的兆科眼科-B(6622.HK)今日再度大涨,盘初一度涨近12%,报1.79港元,股价创2024年10月8日以来新高。 公开资料显示,兆科眼科专注于眼科用药的研发、生产及销售。公司已建立起由创新药及仿制药组成的产品研发组合,涵盖影响眼前节及眼后节的6种主要眼科适应症,包括干眼症、近视、老花眼、湿性老年黄斑部病变、糖尿病黄斑水肿及青光眼。此前,兆科眼科宣布用于控制儿童近视加深的药物NVK002(0.01%低剂量阿托品)的简易新药申请,获国家药监局正式受理。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10